MERONEM Side Effects

6801564-0 | Cholestasis, Jaundice, Multi-organ Failure
on Jun 25, 2010 Female patient from GERMANY , weighting 189.6 lb, was diagnosed with peritonitis, sepsis (What is sepsis?), septic shock, haemostasis and was treated with Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, jaundice (What is jaundice?), multi-organ failure. Meronem dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), VANCOMYCIN (According To Level) (View Vancomycin Review and Vancomycin Label ), PIPRIL (View Pipril Review and Pipril Label ), COMBACTAM (View Combactam Review and Combactam Label ). Patient was hospitalized.

6790272-0 | Pruritus, Rash Macular
Patient was taking Meronem (View Usage). Patient had the following side effects: pruritus, rash macular on Jun 16, 2010 from JAPAN Additional patient health information: Male patient , 16 years of age, weighting 105.8 lb, was diagnosed with cystic fibrosis, cor pulmonale chronic, pancreatic insufficiency, productive cough and. Meronem dosage: . During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), CREON (View Creon Review and Creon Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), TOBI (View Tobi Review and Tobi Label ).

6779669-2 | Cerebral Haemorrhage, Thrombocytopenia
Adverse event was reported on Jun 11, 2010 by a Female patient taking Meronem (View Usage) (Dosage: ) was diagnosed with infection (What is infection?), pain (What is pain?) and. Location: SPAIN , 65 years of age, After Meronem was administered, patient had the following side effects: cerebral haemorrhage, thrombocytopenia. During the same period patient was treated with ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), NOLOTIL (View Nolotil Review and Nolotil Label ), CLEXANE (View Clexane Review and Clexane Label ). Patient was hospitalized.

6751888-0 | Cerebral Haemorrhage, Thrombocytopenia
on May 25, 2010 Male patient from SPAIN , 65 years of age, was diagnosed with infection (What is infection?), pain (What is pain?) and was treated with Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, thrombocytopenia. Meronem dosage: . During the same period patient was treated with ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), NOLOTIL (View Nolotil Review and Nolotil Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.


6713063-5 | Serotonin Syndrome
on Apr 27, 2010 Male patient from GREECE , 75 years of age, was diagnosed with respiratory tract infection, depression (What is depression?) and was treated with Meronem (View Usage). Patient had the following side effects: serotonin syndrome. Meronem dosage: . During the same period patient was treated with CIPROXIN (View Ciproxin Review and Ciproxin Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6615103-0 | Intravascular Haemolysis
Patient was taking Meronem (View Usage). After Meronem was administered, patient had the following side effects: intravascular haemolysis on Mar 01, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 64 years of age, weighting 176.4 lb, was diagnosed with sepsis (What is sepsis?) and. Meronem dosage: . During the same period patient was treated with NORADRENALINE (Throughout Itu Stay) (View Noradrenaline Review and Noradrenaline Label ), PROPOFOL (Throughout Itu Stay) (View Propofol Review and Propofol Label ), FENTANYL (Throughout Itu Stay) (View Fentanyl Review and Fentanyl Label ), PANTOPRAZOLE (Throughout Itu Stay) (View Pantoprazole Review and Pantoprazole Label ), HEPARIN (Throughout Itu Stay) (View Heparin Review and Heparin Label ).

6587977-3 | Thrombocytopenia
Adverse event was reported on Feb 13, 2010 by a Male patient taking Meronem (View Usage) (Dosage: ) was diagnosed with septic shock, ulcer (What is ulcer?), bowel movement irregularity, polyuria and. Location: JORDAN , 73 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: thrombocytopenia. During the same period patient was treated with DOPAMINE HYDROCHLORIDE (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ), NORADRENALINE (View Noradrenaline Review and Noradrenaline Label ), NEXIUM (View Nexium Review and Nexium Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ). Patient was hospitalized.

6576348-1 | Thrombocytopenia
on Feb 01, 2010 Female patient from INDIA , 42 years of age, was diagnosed with acute respiratory distress syndrome and was treated with Meronem (View Usage). Patient had the following side effects: thrombocytopenia. Meronem dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

6557739-1 | Hepatitis
on Jan 20, 2010 Male patient from SPAIN , 42 years of age, was diagnosed with brain neoplasm, prophylaxis and was treated with Meronem (View Usage). After Meronem was administered, patient had the following side effects: hepatitis (What is hepatitis?). Meronem dosage: . During the same period patient was treated with ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), NOLOTIL (View Nolotil Review and Nolotil Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), FENITOINE (View Fenitoine Review and Fenitoine Label ).

6464141-X | Renal Failure
Patient was taking Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure on Nov 27, 2009 from VIET NAM Additional patient health information: Male patient , 52 years of age, weighting 141.1 lb, was diagnosed with meningitis bacterial and. Meronem dosage: . During the same period patient was treated with CEPHALOSPORIN (View Cephalosporin Review and Cephalosporin Label ), QUINOLON (View Quinolon Review and Quinolon Label ).

6460831-3 | Renal Failure
Adverse event was reported on Nov 23, 2009 by a Male patient taking Meronem (View Usage) (Dosage: ) was diagnosed with meningitis bacterial and. Location: VIET NAM , 52 years of age, Patient had the following side effects: renal failure. During the same period patient was treated with CEPHALOSPORIN (View Cephalosporin Review and Cephalosporin Label ), QUINOLON (View Quinolon Review and Quinolon Label ).

6441653-6 | Liver Disorder
on Nov 06, 2009 Male patient from PORTUGAL , 75 years of age, weighting 154.3 lb, was diagnosed with bronchopneumonia and was treated with Meronem (View Usage). After Meronem was administered, patient had the following side effects: liver disorder. Meronem dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6405069-0 | Hepatitis Acute
on Oct 08, 2009 Female patient from SPAIN , 33 years of age, was diagnosed with lung abscess and was treated with Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute. Meronem dosage: . During the same period patient was treated with ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), AMIKACINA (View Amikacina Review and Amikacina Label ), TRIMETOPRIMA+SULFAMETOXAXAZOL=COTRIMOXAZOL (View Trimetoprima+sulfametoxaxazol=cotrimoxazol Review and Trimetoprima+sulfametoxaxazol=cotrimoxazol Label ).

6335192-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Convulsion
Patient was taking Meronem (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, convulsion on Aug 21, 2009 from RUSSIAN FEDERATION Additional patient health information: Male patient , 19 years of age, was diagnosed with pneumonia (What is pneumonia?), pseudomonas infection and. Meronem dosage: .

6316174-1 | Malaise, Pruritus, Urticaria, Vomiting
Adverse event was reported on Aug 11, 2009 by a Female patient taking Meronem (View Usage) (Dosage: ) was diagnosed with wound infection bacterial and. Location: KENYA , weighting 132.3 lb, After Meronem was administered, patient had the following side effects: malaise, pruritus, urticaria, vomiting. During the same period patient was treated with BACQUIRE (View Bacquire Review and Bacquire Label ).

6264002-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Convulsion
on Jul 01, 2009 Male patient from RUSSIAN FEDERATION , 19 years of age, was diagnosed with pneumonia (What is pneumonia?), pseudomonas infection and was treated with Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, convulsion. Meronem dosage: .

6252277-8 | Anaphylactic Shock, Rash, Rash Papular
on Jun 24, 2009 Female patient from COLOMBIA , 28 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Meronem (View Usage). Patient had the following side effects: anaphylactic shock, rash (What is rash?), rash papular. Meronem dosage: . Patient was hospitalized.

6220718-8 | Pancytopenia
Patient was taking Meronem (View Usage). After Meronem was administered, patient had the following side effects: pancytopenia on Jun 04, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 17 years of age, was diagnosed with enterobacter infection and. Meronem dosage: . During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

6219321-5 | Convulsion
Adverse event was reported on Jun 01, 2009 by a Female patient taking Meronem (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: RUSSIAN FEDERATION , 18 years of age, Patient experienced the following unwanted or unexpected effects: convulsion.

6209715-6 | Intravascular Haemolysis
on May 27, 2009 Female patient from UNITED KINGDOM , 64 years of age, weighting 176.4 lb, was diagnosed with sepsis (What is sepsis?) and was treated with Meronem (View Usage). Patient had the following side effects: intravascular haemolysis. Meronem dosage: . During the same period patient was treated with NORADRENALINE (Throughout Itu Stay) (View Noradrenaline Review and Noradrenaline Label ), PROPOFOL (Throughout Itu Stay) (View Propofol Review and Propofol Label ), FENTANYL (Throughout Itu Stay) (View Fentanyl Review and Fentanyl Label ), PANTOPRAZOLE SODIUM (Throughout Itu Stay) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), HEPARIN (Throughout Itu Stay) (View Heparin Review and Heparin Label ).

6188054-6 | Cytolytic Hepatitis
on May 04, 2009 Female patient from FRANCE , 31 years of age, was treated with Meronem (View Usage). After Meronem was administered, patient had the following side effects: cytolytic hepatitis. Meronem dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), DAPTOMYCIN (View Daptomycin Review and Daptomycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ZYVOXID (View Zyvoxid Review and Zyvoxid Label ). Patient was hospitalized.

6175716-X | Blood Alkaline Phosphatase Increased, Prothrombin Level Decreased, Transaminases Increased
Patient was taking Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, prothrombin level decreased, transaminases increased on Apr 23, 2009 from SWEDEN Additional patient health information: Male patient , 74 years of age, was diagnosed with sepsis (What is sepsis?), osteitis and. Meronem dosage: .

6168617-4 | Septic Embolus
Adverse event was reported on Apr 21, 2009 by a Female patient taking Meronem (View Usage) (Dosage: 3 X 1gr) was diagnosed with pneumonia (What is pneumonia?), prophylaxis, endocarditis (What is endocarditis?) and. Location: BELGIUM , 40 years of age, weighting 170.0 lb, Patient had the following side effects: septic embolus. During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), SOLU MEDROL (2 X 20 Mg) (View Solu-medrol Review and Solu-medrol Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), FRAXODI (View Fraxodi Review and Fraxodi Label ).

6158268-X | Anaphylactic Reaction
on Apr 14, 2009 Male patient from UNITED KINGDOM , 25 years of age, weighting 96.34 lb, was treated with Meronem (View Usage). After Meronem was administered, patient had the following side effects: anaphylactic reaction. Meronem dosage: 2 Grams.

6146690-7 | Septic Embolus
on Mar 31, 2009 Female patient from BELGIUM , 40 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: septic embolus. Meronem dosage: 3x1. During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ).

6142721-9 | Toxic Epidermal Necrolysis
Patient was taking Meronem (View Usage). Patient had the following side effects: toxic epidermal necrolysis on Mar 31, 2009 from COLOMBIA Additional patient health information: Male patient , 23 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Meronem dosage: .

6115346-9 | Clostridial Infection, Diarrhoea, Pseudomembranous Colitis, Pyrexia
Adverse event was reported on Feb 18, 2009 by a Male patient taking Meronem (View Usage) (Dosage: ) was diagnosed with encephalitis (What is encephalitis?), prophylaxis, convulsion and. Location: MALAYSIA , 15 years of age, After Meronem was administered, patient had the following side effects: clostridial infection, diarrhoea, pseudomembranous colitis, pyrexia. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

6073545-9 | Grand Mal Convulsion
on Feb 09, 2009 Female patient from SOUTH AFRICA , 43 years of age, weighting 242.5 lb, was diagnosed with pseudomonas infection, pain management and was treated with Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion. Meronem dosage: . During the same period patient was treated with MORPHINE (1 Mg To 5 Mg Every One To Two Hours) (View Morphine Review and Morphine Label ), MIDAZOLAM HCL (1 Mg To 3 Mg Every One To Two Hours) (View Midazolam Hcl Review and Midazolam Hcl Label ).

6072232-0 | Coagulation Factor Decreased, Thrombocytopenia
on Feb 02, 2009 Female patient from GERMANY , 43 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Meronem (View Usage). Patient had the following side effects: coagulation factor decreased, thrombocytopenia. Meronem dosage: . During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), NEXIUM (View Nexium Review and Nexium Label ).

6057568-1 | Grand Mal Convulsion
Patient was taking Meronem (View Usage). After Meronem was administered, patient had the following side effects: grand mal convulsion on Jan 20, 2009 from SOUTH AFRICA Additional patient health information: Female patient , 43 years of age, weighting 242.5 lb, was diagnosed with pseudomonas infection, pain management and. Meronem dosage: . During the same period patient was treated with MORPHINE (1 Mg To 5 Mg Every One To Two Hours) (View Morphine Review and Morphine Label ), MIDAZOLAM HCL (1 Mg To 3 Mg Every One To Two Hours) (View Midazolam Hcl Review and Midazolam Hcl Label ).

6042363-X | Partial Seizures
Adverse event was reported on Jan 12, 2009 by a Male patient taking Meronem (View Usage) (Dosage: 3 X 1g) was diagnosed with pyrexia, respiratory tract infection, prophylaxis and. Location: BELGIUM , 72 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: partial seizures. During the same period patient was treated with POLYVITAMINS (View Polyvitamins Review and Polyvitamins Label ), TPN (View Tpn Review and Tpn Label ), PROPHYLACTIC TREATMENT (View Prophylactic Treatment Review and Prophylactic Treatment Label ). Patient was hospitalized.

6034918-3 | Partial Seizures
on Jan 08, 2009 Male patient from BELGIUM , 72 years of age, weighting 176.4 lb, was diagnosed with pyrexia, respiratory tract infection, prophylaxis and was treated with Meronem (View Usage). Patient had the following side effects: partial seizures. Meronem dosage: . During the same period patient was treated with POLYVITAMINS (View Polyvitamins Review and Polyvitamins Label ), TPN (View Tpn Review and Tpn Label ), PROPHYLACTIC TREATMENT (View Prophylactic Treatment Review and Prophylactic Treatment Label ). Patient was hospitalized.

5908938-0 | Dysaesthesia, Paraesthesia, Polyneuropathy
on Sep 30, 2008 Male patient from DENMARK , weighting 167.6 lb, was diagnosed with sepsis (What is sepsis?) and was treated with Meronem (View Usage). After Meronem was administered, patient had the following side effects: dysaesthesia, paraesthesia, polyneuropathy. Meronem dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ).

5879616-1 | Anaphylactic Reaction
Patient was taking Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction on Sep 02, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 60 years of age, . Meronem dosage: 1 Gram Given Intravenously With Another Dose Of 1gram Given Later That Day.. Patient was hospitalized.

5846495-8 | Hepatitis
Adverse event was reported on Aug 13, 2008 by a Female patient taking Meronem (View Usage) (Dosage: ) was diagnosed with respiratory tract infection, convulsion prophylaxis and. Location: SPAIN , 31 years of age, Patient had the following side effects: hepatitis (What is hepatitis?). During the same period patient was treated with FENITOINE (View Fenitoine Review and Fenitoine Label ), ZYVOXID (View Zyvoxid Review and Zyvoxid Label ).

5829109-2 | Bone Marrow Failure
on Jul 29, 2008 Female patient from GERMANY , weighting 176.4 lb, was diagnosed with pneumonia aspiration, catheter related infection and was treated with Meronem (View Usage). After Meronem was administered, patient had the following side effects: bone marrow failure. Meronem dosage: .

5829100-6 | Bone Marrow Failure
on Jul 29, 2008 Female patient from GERMANY , weighting 176.4 lb, was diagnosed with pneumonia aspiration, catheter related infection and was treated with Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure. Meronem dosage: .

5740468-1 | Status Epilepticus
Patient was taking Meronem (View Usage). Patient had the following side effects: status epilepticus on Apr 08, 2008 from SPAIN Additional patient health information: Female patient , 25 years of age, was diagnosed with pneumonia (What is pneumonia?), epilepsy (What is epilepsy?), factor v leiden mutation and. Meronem dosage: . During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), PLAVIX (View Plavix Review and Plavix Label ), DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

5629739-7 | Hepatic Failure
Adverse event was reported on Feb 13, 2008 by a Female patient taking Meronem (View Usage) (Dosage: ) . Location: SPAIN , 36 years of age, After Meronem was administered, patient had the following side effects: hepatic failure. During the same period patient was treated with SUMIAL (View Sumial Review and Sumial Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ), SEPTRIN FORTE (View Septrin Forte Review and Septrin Forte Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), ACFOL (View Acfol Review and Acfol Label ), TARGOCID (View Targocid Review and Targocid Label ), ZANTAC (View Zantac Review and Zantac Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ).

5513224-7 | Status Epilepticus
on Nov 07, 2007 Female patient from SPAIN , 25 years of age, was diagnosed with pneumonia (What is pneumonia?), convulsion, status epilepticus, factor v leiden mutation and was treated with Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: status epilepticus. Meronem dosage: . During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), PLAVIX (View Plavix Review and Plavix Label ), DEPAKENE (View Depakene Review and Depakene Label ), AMOXICILLIN + CLAVULANIC (View Amoxicillin + Clavulanic Review and Amoxicillin + Clavulanic Label ). Patient was hospitalized.

5476028-X | Multi-organ Failure
on Oct 01, 2007 Male patient from PHILIPPINES , child 2 years of age, weighting 22.05 lb, was diagnosed with pneumonia (What is pneumonia?), wheezing, pneumonia primary atypical and was treated with Meronem (View Usage). Patient had the following side effects: multi-organ failure. Meronem dosage: Source: Hospital Pharmacy. Administration Started On Third Hospital Day. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), SALBUTAMOL (Eight Days Prior To Admission) (View Salbutamol Review and Salbutamol Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ).

5473256-4 | Multi-organ Failure
Patient was taking Meronem (View Usage). After Meronem was administered, patient had the following side effects: multi-organ failure on Sep 27, 2007 from PHILIPPINES Additional patient health information: Male patient , child 2 years of age, weighting 22.05 lb, was diagnosed with pneumonia (What is pneumonia?), wheezing, pneumonia primary atypical and. Meronem dosage: Source: Hospital Pharmacy. Administration Started On Third Hospital Day. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), SALBUTAMOL (Eight Days Prior To Admission) (View Salbutamol Review and Salbutamol Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ).

5467193-9 | Hypotension, Pyrexia
Adverse event was reported on Mar 23, 2007 by a Male patient taking Meronem (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?) and. Location: PHILIPPINES , 49 years of age, Patient experienced the following unwanted or unexpected effects: hypotension, pyrexia. During the same period patient was treated with METFORMIN HCL (More Than 5 Years) (View Metformin Hcl Review and Metformin Hcl Label ), LOGIMAX (Poor Compliance For More Than 5 Years) (View Logimax Review and Logimax Label ). Patient was hospitalized.

5465695-2 | Pyrexia
on Mar 23, 2007 Male patient from PHILIPPINES , 72 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Meronem (View Usage). Patient had the following side effects: pyrexia. Meronem dosage: . Patient was hospitalized.

5456393-X | Arthralgia
on Sep 11, 2007 Female patient from FRANCE , 16 years of age, was diagnosed with lung infection pseudomonal, pneumonia (What is pneumonia?) and was treated with Meronem (View Usage). After Meronem was administered, patient had the following side effects: arthralgia. Meronem dosage: . During the same period patient was treated with CIFLOX (View Ciflox Review and Ciflox Label ), COLIMYCINE (View Colimycine Review and Colimycine Label ), NEBCIN (View Nebcin Review and Nebcin Label ), FORTUM (View Fortum Review and Fortum Label ). Patient was hospitalized.

5451349-5 | Multi-organ Failure
Patient was taking Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure on Sep 10, 2007 from PHILIPPINES Additional patient health information: Male patient , child 2 years of age, weighting 22.05 lb, was diagnosed with pneumonia (What is pneumonia?), wheezing, pneumonia primary atypical and. Meronem dosage: Source: Hospital Pharmacy. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (View Ipratropium Bromide And Albuterol Sulfate Review and Ipratropium Bromide And Albuterol Sulfate Label ).

5380588-7 | Tremor
Adverse event was reported on Jun 25, 2007 by a Female patient taking Meronem (View Usage) (Dosage: ) was diagnosed with pyrexia and. Location: PHILIPPINES , 65 years of age, Patient had the following side effects: tremor. During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ). Patient was hospitalized.

5355711-0 | Anaphylactic Reaction
on Jun 08, 2007 Female patient from UNITED KINGDOM , 17 years of age, weighting 99.21 lb, was treated with Meronem (View Usage). After Meronem was administered, patient had the following side effects: anaphylactic reaction. Meronem dosage: . During the same period patient was treated with ATROVENT (View Atrovent Review and Atrovent Label ), CREON (View Creon Review and Creon Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), MOXIFLOXACIN HCL (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), MULTIVITAMIN PREPARATION (View Multivitamin Preparation Review and Multivitamin Preparation Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

5280581-9 | Loss Of Consciousness, Multi-organ Failure, Nosocomial Infection, Pneumonia, Sepsis
on Mar 13, 2007 Female patient from PHILIPPINES , 52 years of age, was diagnosed with meningitis (What is meningitis?) and was treated with Meronem (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, multi-organ failure, nosocomial infection, pneumonia (What is pneumonia?), sepsis (What is sepsis?). Meronem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ).

5266194-3 | Pyrexia
Patient was taking Meronem (View Usage). Patient had the following side effects: pyrexia on Mar 13, 2007 from PHILIPPINES Additional patient health information: Male patient , 72 years of age, was diagnosed with sepsis (What is sepsis?) and. Meronem dosage: . Patient was hospitalized.